PetVivo Inc. (PETV)
0.61
-0.02 (-3.48%)
At close: Apr 04, 2025, 2:11 PM
-3.48% (1D)
| Bid | 0.55 |
| Market Cap | 13.54M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.44 |
| PE Ratio (ttm) | -1.39 |
| Forward PE | -0.97 |
| Analyst | n/a |
| Ask | 0.61 |
| Volume | 1,400 |
| Avg. Volume (20D) | 21,134 |
| Open | 0.57 |
| Previous Close | 0.63 |
| Day's Range | 0.57 - 0.61 |
| 52-Week Range | 0.29 - 1.25 |
| Beta | 1.86 |
About PETV
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeut...
Industry Medical - Devices
Sector Healthcare
IPO Date Sep 8, 2014
Employees 20
Stock Exchange OTC
Ticker Symbol PETV
Website https://www.petvivo.com
